Scholarlink

Introduction <p>There is an increasing recognition for local strategies in managing metastatic breast cancer. This case report shows the potential role of ablative trans-arterial radioembolization in a patient with liver metastasis.</p> Case presentation <p>A 66-year-old female patient with oligoprogressive breast cancer presented with progressive intra-hepatic disease. She underwent trans-arterial radioembolization with an ablative approach (200&#xa0;Gy) for liver metastasis in segment VII and VIII. The patient had minimal side-effects and resumed chemotherapy one month post-treatment. A persisting complete response was achieved after 3 years of follow-up.</p> Conclusion <p>This case report highlights the efficacy of ablative trans-arterial radioembolization in treating liver metastases from breast cancer.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Yttrium-90 transarterial radioembolization as an ablative approach for oligoprogressive breast cancer: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月31日

查看全文
  • Charlotte Schneider,
  • Tarik Baetens,
  • Marloes van Dongen,
  • Regina Beets-Tan,
  • Fernando Gómez Munõz,
  • Vincent Dezentjé,
  • Belinda de Wit-,
  • van der Veen,
  • Elisabeth G. Klompenhouwer

摘要

Introduction

There is an increasing recognition for local strategies in managing metastatic breast cancer. This case report shows the potential role of ablative trans-arterial radioembolization in a patient with liver metastasis.

Case presentation

A 66-year-old female patient with oligoprogressive breast cancer presented with progressive intra-hepatic disease. She underwent trans-arterial radioembolization with an ablative approach (200 Gy) for liver metastasis in segment VII and VIII. The patient had minimal side-effects and resumed chemotherapy one month post-treatment. A persisting complete response was achieved after 3 years of follow-up.

Conclusion

This case report highlights the efficacy of ablative trans-arterial radioembolization in treating liver metastases from breast cancer.